Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25791389 | 0.91 | KDM4E (0.31) | PKMALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL23515597 | 0.87 | KMT2A (0.36) | KMT2AMEN1PKMALDH1A1MAPT | |
| SCHEMBL20042525 | 0.84 | KMT2A (0.34) | KMT2AMEN1PKMALDH1A1MAPT | |
| SCHEMBL24759646 | 0.83 | — | — | |
| SCHEMBL21776017 | 0.83 | KMT2A (0.34) | KMT2AMEN1PKMALDH1A1MAPT | |
| SCHEMBL24119923 | 0.82 | KMT2A (0.31) | KMT2AMEN1PKMALDH1A1MAPT | |
| SCHEMBL21775988 | 0.82 | KMT2A (0.31) | KMT2AMEN1PKMALDH1A1MAPT | |
| SCHEMBL23284293 | 0.81 | — | — | |
| SCHEMBL24637732 | 0.81 | CSNK2A2 (0.32) | KMT2AMEN1PKMALDH1A1MAPT | |
| SCHEMBL20044526 | 0.80 | PDE4A (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210323974-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE INCLUDING SAME | LG CHEM, LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323974-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE INCLUDING SAME | ODC1, AOX1, CYP1A1 | KMT2A 468/4885MEN1 405/4885PKM 1815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.